Antimicrobial resistance surveillance in urinary tract infections in primary care.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2016-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jac/dkw223PMID 27353470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) 2010 to 2014: report 2015

  2015cited by this paper
• Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.

  2015cited by this paper
• Recommendations for the Empirical Treatment of Complicated Urinary Tract Infections Using Surveillance Data on Antimicrobial Resistance in the Netherlands

  2014cited by this paper
• Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)

  2013cited by this paper
• Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.

  2012cited by this paper
• Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia

  2011cited by this paper
• International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

  2011cited by this paper
• Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women : A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

  2011cited by this paper
• Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?

  2011cited by this paper
• Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.

  2008cited by this paper
• Editorial comment on: surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.

  2008cited by this paper
• Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.

  2008cited by this paper
• Risk Factors for Trimethoprim-Sulfamethoxazole Resistance in Patients with Acute Uncomplicated Cystitis

  2007cited by this paper
• Problems of basing patient recruitment for primary care studies on routine laboratory submissions

  2007cited by this paper
• Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care.

  2006cited by this paper
• Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.

  2006cited by this paper
• When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data.

  2006cited by this paper
• Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

  2005cited by this paper
• The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data.

  2005cited by this paper
• Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.

  2005cited by this paper
• Complicated urinary tract infection in adults.

  2005cited by this paper
• Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy.

  2004cited by this paper
• How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England.

  2004cited by this paper
• Can routine laboratory data guide empirical prescribing?

  2004cited by this paper
• An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project.

  2003cited by this paper
• Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

  2003cited by this paper
• Monitoring antibiotic resistance in urinary isolates from the community--a spotter practice model.

  2002cited by this paper
• Impact of guidelines for the diagnosis of urinary tract infection on trimethoprim susceptibility of Escherichia coli.

  2002cited by this paper
• Post-therapy multiply resistant mutant of Pseudomonas aeruginosa.

  2002cited by this paper
• Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

  2002cited by this paper
• How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection?

  2002cited by this paper
• Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.

  2002cited by this paper
• Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.

  2001cited by this paper
• Urinary tract infections: disease panorama and challenges.

  2001cited by this paper
• Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women

  2000cited by this paper
• Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

  2000cited by this paper
• Management of urinary tract infection in general practice: a cost-effectiveness analysis.

  2000cited by this paper
• Urinary tract infection: self-reported incidence and associated costs.

  2000cited by this paper
• Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates

  1999cited by this paper
• Factors associated with trimethoprim-resistant bacteria isolated from urine samples.

  1999cited by this paper
• Recurring urinary tract infection: incidence and risk factors.

  1990cited by this paper
• Diagnosis of coliform infection in acutely dysuric women.

  1982cited by this paper

• Population-based epidemiological analysis of acute pyelonephritis and antibiotic prescription in Spain (2009–2018)

  2025cites this paper
• Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database

  2025cites this paper
• Incidence of urinary infections and pharmacological sensitivity in elective urine samples in a prospective cohort from Luanda, Angola

  2024cites this paper
• Antimicrobial Profile of Pathogens Causing Community Acquired Urinary Tract Infection in Ain Shams University Hospitals

  2023cites this paper
• Detection of extended-spectrum beta-lactamase and scarbapenemase-producing Enterobacteriaceae in Tunisia

  2023cites this paper
• What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?

  2023cites this paper
• Evaluation of the French surveillance system for epidemiological surveillance of antimicrobial resistance in the community and nursing homes

  2022cites this paper
• Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020

  2022cites this paper
• Reviving the role of mecillinam against extended spectrum beta-lactamase producing enterobacterales

  2022cites this paper
• Antibiotic Resistance in COVID-19 with Bacterial Infection: Laboratory-Based Surveillance Study at Single Tertiary Hospital in Indonesia

  2022cites this paper
• Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016–2017

  2022cites this paper
• Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)

  2021cites this paper
• Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.

  2021cites this paper
• Antibiotic resistance features in Klebsiella pneumoniae and Escherichia coli strains isolated from hospital and community acquired urinary tract infections

  2021cites this paper
• Epidemiology and antibiotic resistance in community-acquired lower urinary tract infections in the Milan area

  2020cites this paper
• Antibiotic resistance in urinary tract infections: A re-visit after five years and experience over two sites

  2020cites this paper
• Routine laboratory surveillance of antimicrobial resistance in community-acquired urinary tract infections adequately informs prescribing policy in England

  2020cites this paper
• Obtaining nasal and rectal swabs from general practice patients to assess carriage of antibiotic resistant microorganisms: a feasibility study.

  2020cites this paper
• Clinical diagnosis and treatment of common respiratory tract infections in relation to microbiological profiles in rural health facilities in China: implications for antibiotic stewardship

  2020cites this paper
• Pathways to optimising antibiotic use in rural China: identifying key determinants in community and clinical settings, a mixed methods study protocol

  2019cites this paper
• Is it possible to extrapolate the rates of resistance of Escherichia coli from asymptomatic bacteriuria in pregnant women to those of E. coli in uncomplicated community-acquired UTI?

  2019cites this paper
• [Antimicrobial Susceptibility Patterns in Outpatient Urinary Tract Infection in the District of Coimbra, Portugal: A Cross-Sectional Study].

  2019cites this paper
• Community acquired urinary tract infections among adults in Accra, Ghana

  2019cites this paper
• Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection.

  2018cites this paper
• Assessment, management and prevention of urinary tract infections in men.

  2018cites this paper
• Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community

  2018cites this paper
• Antibiotic use, knowledge and health literacy among the general population in Berlin, Germany and its surrounding rural areas

  2018cites this paper
• Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform

  2018cites this paper
• Global research output in antimicrobial resistance among uropathogens: A bibliometric analysis (2002-2016).

  2017cites this paper
• ESBL-producing Escherichia coli 
and Its Rapid Rise among Healthy People.

  2017cites this paper
• Antimicrobial susceptibility of microorganisms that cause urinary tract infections in pediatric patients.

  2017cites this paper
• Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001–2015

  2017cites this paper
• Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia

  2017cites this paper
• Determination of Secondary Encounter Rates for Urinary Tract Infections in Patients Treated with Cephalexin

  2016cites this paper
• Specimen collection technique and standards for diagnosing urinary tract infections

  2016cites this paper
• Tratamiento empírico antibiótico de los síndromes infecciosos más prevalentes

  2016cites this paper